Since mechanical circulatory support (MCS) devices have become integral component in
the therapy of refractory cardiogenic shock (RCS), we identified 67 patients in biventricular …

Background Cardiogenic shock remains a clinical challenge with high mortality rate.
Mechanical circulatory support (MCS) devices have become an integral component of the …

Background Patients with refractory post-cardiac arrest (CA) cardiogenic shock (RCS) may
present with LV-failure, biventricular failure or even combined cardiopulmonary failure …

Objective To evaluate the outcomes of patients supported with Impella (CP/5.0) or
venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock …

Mechanical circulatory support (MCS) devices are effective tools in managing refractory
cardiogenic shock (CS). Data comparing veno-arterial extracorporeal membrane …

Background: Limited progress has been made in the management of cardiogenic shock
(CS). Morbidity and mortality of refractory CS remain high. The effects of mechanical …

Background Despite advances in management of cardiogenic shock (CS), its mortality
remains unacceptably high particularly if refractory. The evolving field of mechanical support …

Background Use of acute mechanical circulatory support (AMCS) devices for cardiogenic
shock (CS) is growing and includes veno-arterial extracorporeal oxygenation (VA-ECMO) or …

Cardiogenic shock (CS) is most commonly caused by acute myocardial infarc-tion,
accounting for 80% of cases. 1 Despite improvements in revascularization and systems of …

Background Percutaneous mechanical circulatory support (pMCS) devices are increasingly
used in patients with cardiogenic shock (CS) in order to augment cardiac output, stabilize …